PBYI - Puma Biotechnology EPS beats by $0.20 beats on revenue August, 06 2020 04:09 PM Puma Biotechnology Inc Puma Biotechnology (NASDAQ:PBYI): Q2 Non-GAAP EPS of $0.35 beats by $0.20; GAAP EPS of $0.08 beats by $0.38.More news on: Puma Biotechnology, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...